==== Front J Family Med Prim CareJ Family Med Prim CareJFMPCJournal of Family Medicine and Primary Care2249-48632278-7135Medknow Publications & Media Pvt Ltd India JFMPC-7-53810.4103/jfmpc.jfmpc_7_17Original ArticleMusculoskeletal manifestations of tuberculosis: An observational study Gupta Nikhil 12Bhatnagar Anuj K 121 Department of Clinical Immunology and Rheumatology, CMC, Vellore, Tamil Nadu, India2 Department of Clinical Immunology and Rheumatology, Max Shalimar Bagh Hospital, New Delhi, IndiaAddress for correspondence: Dr. Nikhil Gupta, Department of Medicine, University College of Medical Sciences and Guru Teg Bahadur Hospital, University of Delhi, Dilshad Garden, New Delhi, India. E-mail: drnikhilguptamamc@gmail.comMay-Jun 2018 7 3 538 541 Copyright: © 2018 Journal of Family Medicine and Primary Care2018This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.Background: Data of musculoskeletal manifestations of tuberculosis (TB) are limited to case reports, series, or retrospective studies. Therefore, we conducted this study to create awareness among doctors about musculoskeletal manifestations of TB. Materials and Methods: This was a prospective observational study conducted at a referral TB Hospital in North India in September and October 2016. The aim of our study was to study musculoskeletal manifestations of TB. We included patients who had active TB as per the World Health Organization 2010 criteria. Patients with other chronic illnesses were excluded. A detailed history, examination, and appropriate investigations (blood, urine, serological, and radiological) of the 100 consecutive patients fulfilling the inclusion criteria were recorded. Results: The mean age of patients was 32.16 ± 12.93 years. Male-to-female ratio was 43:57. The mean duration of disease was 6.85 ± 8.83 months. Of the 100 patients, 60 (60%) had pulmonary TB. The mean duration of antitubercular therapy was 1.79 ± 1.34 months. Fibromyalgia was classified in 21 (21%) patients, polyarthralgia was seen in 9 (9%), Pott's spine in 7 (7%), osteomyelitis in 4 (4%), and scleritis in 2 (2%) patients. Uveitis, tenosynovitis, erythema induratum, subcutaneous abscess, and dactylitis were seen in 1 (1%) patient each. In 21 patients who had fibromyalgia, 11 developed fibromyalgia with the second episode of TB amounting to 60.75% patients. Conclusion: This is the first prospective study to look at the musculoskeletal manifestations of TB. Patients with active TB were found to have various rheumatological manifestations. FibromyalgiaosteomyelitisPoncet'sPott's spinerheumatologyTuberculosisuveitis ==== Body Introduction Tuberculosis (TB) infection is a major public health problem around the world. In recent years, there has been a rise in the prevalence of TB in many parts of Europe due to migration of people from countries that are endemic with TB and various socioeconomic factors. The musculoskeletal system is involved in 1%–3% of the cases, and of these only 50% involve the extraspinal bones and soft tissues. The association of TB and rheumatologic diseases is bidirectional.[123] In this association, Mycobacterium tuberculosis (MTB) can directly infect the musculoskeletal system. Further, patients with rheumatologic diseases are predisposed to develop TB due to the immunosuppressive state, the disease itself, or drug-induced immunosuppression. Direct manifestations of TB musculoskeletal involvement include spondylitis, septic arthritis, osteomyelitis, myositis, bursitis, subcutaneous abscesses, or tenosynovitis.[3] Immunologic reactions such as reactive arthritis (Poncet's), erythema nodosum, erythema induratum, or secondary amyloidosis may also manifest as a tubercular rheumatism.[4567] In addition, drugs used in the management of TB can also lead to arthropathy or tendinopathy, especially with the use of rifampin or fluoroquinolones,[8910] drug-induced lupus (DILE) by isoniazid or rifampin,[1112] and arthralgias and gout due to pyrazinamide.[13] Secondary fibromyalgia or chronic pain syndrome may be a manifestation of TB. These rheumatological or musculoskeletal manifestations may be the presenting symptoms of TB. TB is a common illness in developing country like India, and if not detected at an early stage, it may lead to increased morbidity and mortality. Thus, it is important to have knowledge about these musculoskeletal manifestations for the treating doctors. Data of musculoskeletal manifestations of TB are limited to case reports, series, or retrospective study. To our knowledge, there is no prospective study addressing this issue. Therefore, we conducted this study to create awareness among doctors about musculoskeletal manifestations of TB. Materials and Methods It was a prospective observational study which was conducted at Rajan Babu Tuberculosis Hospital, Kingsway Camp, New Delhi, in the months of September and October 2016. Consecutive patients from outpatient and inpatient department of pulmonology were recruited irrespective of the duration of antitubercular therapy. We included patients who were a confirmed case of active TB as per World Health Organization 2010 criteria.[14] Patients with chronic illness except TB were excluded. Patients fulfilling the inclusion criteria were recruited for the study. A detailed history, examination, and appropriate investigations (blood, urine, and radiological) of the 100 consecutive patients fulfilling the inclusion criteria were recorded. Musculoskeletal manifestations of TB which were looked at in patients are summarized in Table 1. Table 1 Musculoskeletal manifestations of tuberculosis Diagnosis of Poncet's disease was made clinically by oligo or polyarticular involvement in the presence of TB.[1516] The classification of fibromyalgia was made by American College of Rheumatology 1990[17] classification criteria for fibromyalgia. The patient was classified as gout according to American College of Rheumatology–European League Against Rheumatism 2015 classification criteria for Gout.[18] The patient was classified as DILE in the presence of lupus-like symptoms (commonly fever, musculoskeletal involvement, and serositis) which was temporally related to continuous drug exposure (>1 month) which resolves with cessation of the offending drug and the patient may have positive antinuclear antibody and anti-histone antibodies with negative antibodies to dsDNA.[19] The diagnosis of the rest of musculoskeletal manifestations was clinical, microbiological, radiological, histopathological, joint aspiration, opthalmological, or serological depending on the manifestation. Statistical analysis Age and duration of disease are represented as mean ± standard deviation. Results The prospective study was carried out at Rajan Babu Tuberculosis Hospital. Consecutive patients who presented to the inpatient and outpatient department of respiratory and TB department were recruited. Those patients who fulfilled the inclusion and exclusion criteria were included in the study. The baseline characteristics of the study cohort are shown in Table 2. Many patients were found to have rheumatological manifestations. Table 3 shows rheumatological manifestations in patients with TB. Table 2 Baseline characteristic of the study group Table 3 Rheumatological manifestations in patients with tuberculosis (n=100) Rheumatological manifestations such as septic arthritis, DILE, Poncet's arthritis, tendinopathy, amyloidosis, gout, erythema nodosum, and myositis were not seen in any patient. Fibromyalgia was classified in 21 (21%) patients. Of these 21 patients, 11 patients developed fibromyalgia in patients with second episode of TB amounting to 60.75% patients developing fibromyalgia who had second episode of TB. Of these 21 patients of fibromyalgia, 12 were female. Discussion Our study is the first prospective study of its kind to look at rheumatological manifestations in patients with active TB. Fibromyalgia is the second most common rheumatic disease. The prevalence is from 2% to 8% of the population depending on the diagnostic criteria used.[20] Fibromyalgia may also occur with other chronic diseases such as osteoarthritis, rheumatoid arthritis, and lupus. Prevalence of fibromyalgia ranges from 10% to 30%[21] in patients with chronic rheumatic disorders. TB is a chronic infection. In our patients with active TB, fibromyalgia was seen in 21% of patients with 60.75% with second episode of TB developing fibromyalgia. There has been no study which has evaluated the incidence or prevalence of fibromyalgia in patients with TB. Pott's spine is a common form of extrapulmonary TB. Around half the cases of skeletal TB are Pott's spine. In total, 1%–2% of total TB cases are attributable to Pott's disease.[22] In our cohort, Pott's spine was seen in 7% of patients with 2% having only Pott's spine and the remaining 5% having pulmonary TB with Pott's spine. Polyarthralgia was observed in 9 (9%) of our study cohort. Arthralgia can be caused by antitubercular drugs as isoniazid[23] and pyrazinamide.[23] All our patients who developed polyarthralgia were on isoniazid or pyrazinamide. Osteomyelitis was seen in 4 (4%) patients. Tubercular osteomyelitis occurs in 1%–2% of all cases of TB and 10% of all cases of extrapulmonary TB.[24] Scleritis was seen in 2 (2%) of our patients. Donahue[25] found 1.4% ocular TB in 10,000 patients with primary pulmonary TB in the United States. In a study recently reported at Srilanka,[26] of the total of 2130 patients with TB, ocular TB was diagnosed in 23 patients among whom episcleritis and inflammatory scleral nodule were observed in 1 patient each. Uveitis, dactylitis, tenosynovitis, subcutaneous abscess, and erythema induratum were seen in 1 (1%) each in patients with active TB. However, a recent study from Japan by Wakabayashi et al.[27] showed an increasing frequency of tuberculous uveitis. Of 189 referred uveitis cases, 6.9% were found to have tuberculous uveitis. According to a study by Mercanti et al.,[28]7% of patients with uveitis in Italy had presumed tuberculous etiology. In India, where pulmonary TB is endemic, TB was the etiology of uveitis in 5.6%[16]–10.1%.[29] Dactylitis was seen in 1 (1%) of our patient. As shown in studies, 7% of children with pulmonary TB may develop dactylitis. In our study cohort, tubercular tenosynovitis was seen in 1 (1%) patient. Our patient developed tenosynovitis of the extensor tendons of right wrist. Subcutaneous abscess and erythema induratum were seen in 1 (1%) patient, who developed breast abscess. The overall incidence of cutaneous TB among all forms of TB is approximately 1%–2%. The nodules are usually seen around the ankles.[30] Limitation of our study: It was a single-center study with relatively small number of subjects. Patients with extrapulmonary TB were quite less when compared with pulmonary TB. Conclusion This is the first prospective study to look at musculoskeletal manifestations of TB. Patients with active TB were found to have secondary fibromyalgia (21%) and polyarthralgia (9%). Other manifestations that were seen were Pott's spine, dactylitis, scleritis, uveitis, tenosynovitis, erythema induratum, and subcutaneous abscess. Financial support and sponsorship It was a self funded project Conflicts of interest There are no conflicts of interest. ==== Refs 1 Rothschild BM Martin LD Lev G Bercovier H Bar-Gal GK Greenblatt C Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present Clin Infect Dis 2001 33 305 11 11438894 2 Santos AL Roberts CA A picture of tuberculosis in young Portuguese people in the early 20th century: A multidisciplinary study of the skeletal and historical evidence Am J Phys Anthropol 2001 115 38 49 11309748 3 Kramer N Rosenstein ED Rheumatologic manifestations of tuberculosis Bull Rheum Dis 1997 46 5 8 4 Southwood T Gaston JSH The molecular basis of Poncet's disease? Br J Rheumatol 1990 29 491 5 Chowdhary V Aggarwal A Misra R Multifocal tuberculous dactylitis in an adult J Clin Rheumatol 2001 8 35 7 6 El-Hennawy AS Goldstein M Nicastri A Renal amyloidosis secondary to tuberculosis of cecum Nephron 2002 92 708 10 12372961 7 Khaliq Y Zhanel GG Fluoroquinolone-associated tendinopathy: A critical review of the literature Clin Infect Dis 2003 36 1404 10 12766835 8 Lipsky BA Baker CA Fluoroquinolone toxicity profiles: A review focusing on newer agents Clin Infect Dis 1999 28 352 64 10064255 9 Siegal FP Eilbott D Burger H Gehan K Davidson B Kaell AT Dose-limiting toxicity of rifabutin in AIDS-related complex: Syndrome of arthralgia/arthritis AIDS 1990 4 433 41 2164820 10 Berning SE Iseman M Rifamycin-induced lupus syndrome Lancet 1997 349 1521 2 11 Shakoor N Michalska M Harris CA Block JA Drug-induced systemic lupus erythematosus associated with etanercept therapy Lancet 2002 359 579 80 11867114 12 Scott JT Drug induced gout Baillieres Clin Rheumatol 1991 5 39 60 2070427 13 Sanchez-Albisua I Vidal ML Joya-Verde G del Castillo F de Jose MI Garcia-Hortelano J Tolerance of pyrazinamide in short course chemotherapy for pulmonary tuberculosis in children Pediatr Infect Dis J 1997 16 760 3 9271037 14 World Health Organization. Treatment of Tuberculosis: Guidelines WHO/HTM/TB/2009.420 2010 4th ed Geneva World Health Organization 15 Abdulaziz S Almoallim H Ibrahim A Samannodi M Shabrawishi M Meeralam Y Poncet's disease (reactive arthritis associated with tuberculosis): Retrospective case series and review of literature Clin Rheumatol 2012 31 1521 8 22855345 16 Garg S Malaviya AN Kapoor S Rawat R Agarwal D Sharma A Acute inflammatory ankle arthritis in northern India – Lofgren's syndrome or Poncet's disease? J Assoc Physicians India 2011 59 87 90 21751642 17 Wolfe F Smythe HA Yunus MB Bennett RM Bombardier C Goldenberg DL The American College of Rheumatology 1990 criteria for the classification of fibromyalgia 1990 33 160 72 18 Neogi T Jansen TL Dalbeth N Fransen J Schumacher HR Berendsen D 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative Ann Rheum Dis 2015 74 1789 98 26359487 19 Sarzi-Puttini P Atzeni F Capsoni F Lubrano E Doria A Drug-induced lupus erythematosus Autoimmunity 2005 38 507 18 16373256 20 Vincent A Lahr BD Wolfe F Clauw DJ Whipple MO Oh TH Prevalence of fibromyalgia: A population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project Arthritis Care Res (Hoboken) 2013 65 786 92 23203795 21 Phillips K Clauw DJ Central pain mechanisms in the rheumatic diseases: Future directions Arthritis Rheum 2013 65 291 302 23045168 22 Beek LA van der Werf MJ Richter C Borgdorff MW Extrapulmonary tuberculosis by nationality, The Netherlands, 1993-2001 Emerg Infect Dis 2006 12 1375 82 17073086 23 Gholami K Kamali E Hajiabdolbagh MI Shalviri G Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients Pharm Pract 2006 4 134 8 24 Rieder HL Snider DE Jr Cauthen GM Extrapulmonary tuberculosis in the United States Am Rev Respir Dis 1990 141 347 51 2301852 25 Donahue HC Ophthalmologic experience in a tuberculosis sanatorium Am J Ophthalmol 1967 64 742 8 6061532 26 Yasaratne BMGD Madegedara D Senanayake NS Senaratne T A case series of symptomatic ocular tuberculosis and the response to anti-tubercular therapy Ceylon Med J 2010 55 1 20446532 27 Wakabayashi T Morimura Y Miyamoto Y Okada AA Changing pattern of intraocular inflammatory disease in Japan Ocul Immunol Inflamm 2003 11 277 86 14704899 28 Mercanti A Parolini B Bonora A Lequaglie Q Tomazzoli L Epidemiology of endogenous uveitis in north-eastern Italy: Analysis of 655 new cases Acta Ophthalmol Scand 2001 79 64 8 11167291 29 Salimpour R Salimpour P Picture of the month. Tuberculous dactylitis Arch Pediatr Adolesc Med 1997 151 851 2 9265892 30 Kuramoto Y Aiba S Tagami H Erythema induratum of bazin as a type of tuberculid J Am Acad Dermatol 1990 22 612 6 2180993